165 related articles for article (PubMed ID: 34696960)
1. Metabolomics and cytokine profiling of mesenchymal stromal cells identify markers predictive of T-cell suppression.
Maughon TS; Shen X; Huang D; Michael AOA; Shockey WA; Andrews SH; McRae JM; Platt MO; Fernández FM; Edison AS; Stice SL; Marklein RA
Cytotherapy; 2022 Feb; 24(2):137-148. PubMed ID: 34696960
[TBL] [Abstract][Full Text] [Related]
2. Development of a Robust Consensus Modeling Approach for Identifying Cellular and Media Metabolites Predictive of Mesenchymal Stromal Cell Potency.
Van Grouw A; Colonna MB; Maughon TS; Shen X; Larey AM; Moore SG; Yeago C; Fernández FM; Edison AS; Stice SL; Bowles-Welch AC; Marklein RA
Stem Cells; 2023 Aug; 41(8):792-808. PubMed ID: 37279550
[TBL] [Abstract][Full Text] [Related]
3. Regulatory-compliant conditions during cell product manufacturing enhance in vitro immunomodulatory properties of infrapatellar fat pad-derived mesenchymal stem/stromal cells.
Kouroupis D; Bowles AC; Greif DN; Leñero C; Best TM; Kaplan LD; Correa D
Cytotherapy; 2020 Nov; 22(11):677-689. PubMed ID: 32723596
[TBL] [Abstract][Full Text] [Related]
4. Media matters: culture medium-dependent hypervariable phenotype of mesenchymal stromal cells.
Fitzgerald JC; Shaw G; Murphy JM; Barry F
Stem Cell Res Ther; 2023 Dec; 14(1):363. PubMed ID: 38087388
[TBL] [Abstract][Full Text] [Related]
5. Comparative analysis of the immunomodulatory capacities of human bone marrow- and adipose tissue-derived mesenchymal stromal cells from the same donor.
Valencia J; Blanco B; Yáñez R; Vázquez M; Herrero Sánchez C; Fernández-García M; Rodríguez Serrano C; Pescador D; Blanco JF; Hernando-Rodríguez M; Sánchez-Guijo F; Lamana ML; Segovia JC; Vicente Á; Del Cañizo C; Zapata AG
Cytotherapy; 2016 Oct; 18(10):1297-311. PubMed ID: 27637760
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Immunosuppression of T Cells by Sustained Presentation of Bioactive Interferon-γ Within Three-Dimensional Mesenchymal Stem Cell Constructs.
Zimmermann JA; Hettiaratchi MH; McDevitt TC
Stem Cells Transl Med; 2017 Jan; 6(1):223-237. PubMed ID: 28170190
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive characterisation of large-scale expanded human bone marrow and umbilical cord mesenchymal stem cells.
Mennan C; Garcia J; Roberts S; Hulme C; Wright K
Stem Cell Res Ther; 2019 Mar; 10(1):99. PubMed ID: 30885254
[TBL] [Abstract][Full Text] [Related]
8. IDO-independent suppression of T cell effector function by IFN-γ-licensed human mesenchymal stromal cells.
Chinnadurai R; Copland IB; Patel SR; Galipeau J
J Immunol; 2014 Feb; 192(4):1491-501. PubMed ID: 24403533
[TBL] [Abstract][Full Text] [Related]
9. Single-cell RNA-seq of out-of-thaw mesenchymal stromal cells shows tissue-of-origin differences and inter-donor cell-cycle variations.
Medrano-Trochez C; Chatterjee P; Pradhan P; Stevens HY; Ogle ME; Botchwey EA; Kurtzberg J; Yeago C; Gibson G; Roy K
Stem Cell Res Ther; 2021 Nov; 12(1):565. PubMed ID: 34736534
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of Immune Suppression Utilized by Canine Adipose and Bone Marrow-Derived Mesenchymal Stem Cells.
Chow L; Johnson V; Coy J; Regan D; Dow S
Stem Cells Dev; 2017 Mar; 26(5):374-389. PubMed ID: 27881051
[TBL] [Abstract][Full Text] [Related]
11. Inducible indoleamine 2,3-dioxygenase 1 and programmed death ligand 1 expression as the potency marker for mesenchymal stromal cells.
Guan Q; Li Y; Shpiruk T; Bhagwat S; Wall DA
Cytotherapy; 2018 May; 20(5):639-649. PubMed ID: 29548707
[TBL] [Abstract][Full Text] [Related]
12. Functional Profiling of Chondrogenically Induced Multipotent Stromal Cell Aggregates Reveals Transcriptomic and Emergent Morphological Phenotypes Predictive of Differentiation Capacity.
Lam J; Bellayr IH; Marklein RA; Bauer SR; Puri RK; Sung KE
Stem Cells Transl Med; 2018 Sep; 7(9):664-675. PubMed ID: 30084545
[TBL] [Abstract][Full Text] [Related]
13. Pancreas-derived mesenchymal stromal cells share immune response-modulating and angiogenic potential with bone marrow mesenchymal stromal cells and can be grown to therapeutic scale under Good Manufacturing Practice conditions.
Thirlwell KL; Colligan D; Mountford JC; Samuel K; Bailey L; Cuesta-Gomez N; Hewit KD; Kelly CJ; West CC; McGowan NWA; Casey JJ; Graham GJ; Turner ML; Forbes S; Campbell JDM
Cytotherapy; 2020 Dec; 22(12):762-771. PubMed ID: 32828673
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profile of immunoregulatory cytokines secreted from bone marrow and adipose derived human mesenchymal stem cells in early and late passages.
Moghadam M; Tokhanbigli S; Baghaei K; Farivar S; Asadzadeh Aghdaei H; Zali MR
Mol Biol Rep; 2020 Mar; 47(3):1723-1732. PubMed ID: 32040706
[TBL] [Abstract][Full Text] [Related]
15. Morphological profiling using machine learning reveals emergent subpopulations of interferon-γ-stimulated mesenchymal stromal cells that predict immunosuppression.
Marklein RA; Klinker MW; Drake KA; Polikowsky HG; Lessey-Morillon EC; Bauer SR
Cytotherapy; 2019 Jan; 21(1):17-31. PubMed ID: 30503100
[TBL] [Abstract][Full Text] [Related]
16. The Utilization of Freezing Steps in Mesenchymal Stromal Cell (MSC) Manufacturing: Potential Impact on Quality and Cell Functionality Attributes.
Oja S; Kaartinen T; Ahti M; Korhonen M; Laitinen A; Nystedt J
Front Immunol; 2019; 10():1627. PubMed ID: 31379832
[TBL] [Abstract][Full Text] [Related]
17. Xenotransplantation of interferon-gamma-pretreated clumps of a human mesenchymal stem cell/extracellular matrix complex induces mouse calvarial bone regeneration.
Takeshita K; Motoike S; Kajiya M; Komatsu N; Takewaki M; Ouhara K; Iwata T; Takeda K; Mizuno N; Fujita T; Kurihara H
Stem Cell Res Ther; 2017 Apr; 8(1):101. PubMed ID: 28446226
[TBL] [Abstract][Full Text] [Related]
18. Characterizing human mesenchymal stromal cells' immune-modulatory potency using targeted lipidomic profiling of sphingolipids.
DeVeaux SA; Ogle ME; Vyshnya S; Chiappa NF; Leitmann B; Rudy R; Day A; Mortensen LJ; Kurtzberg J; Roy K; Botchwey EA
Cytotherapy; 2022 Jun; 24(6):608-618. PubMed ID: 35190267
[TBL] [Abstract][Full Text] [Related]
19. Single-cell RNA sequencing of equine mesenchymal stromal cells from primary donor-matched tissue sources reveals functional heterogeneity in immune modulation and cell motility.
Harman RM; Patel RS; Fan JC; Park JE; Rosenberg BR; Van de Walle GR
Stem Cell Res Ther; 2020 Dec; 11(1):524. PubMed ID: 33276815
[TBL] [Abstract][Full Text] [Related]
20. A reproducible immunopotency assay to measure mesenchymal stromal cell-mediated T-cell suppression.
Bloom DD; Centanni JM; Bhatia N; Emler CA; Drier D; Leverson GE; McKenna DH; Gee AP; Lindblad R; Hei DJ; Hematti P
Cytotherapy; 2015 Feb; 17(2):140-51. PubMed ID: 25455739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
